Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-31

Clinical Trial Update: A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA® [Phase 1]

View source ↗

Summary

A Phase 1 pilot bioavailability study has been completed. It compares levodopa delivered via the Levodopa Cyclops device to INBRIJA (levodopa inhalation powder)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INBRIJA (levodopa inhalation powder)
  • Levodopa Cyclops

Snippet

Sponsor: PureIMS B.V. | Conditions: Parkinson, Parkinson Disease | Phase 1 | Status: COMPLETED